PrecisionHealth Genetic Report
Member
Name: Jane Doe
Member ID: 1234
Sex at Birth: Female
Date of Birth: 12/12/2000
Provider
Name: Dr. Smith
Address: 100 Burdell Dr, Atlanta, GA
Sample Collection
Specimen ID: 3456
Specimen Type: Saliva
Amount: >2mL
Collection Tube: DNA Genotek Oragene•DNA (OG-600)
Collected: 6/24/2024
Sequencing
Test ID: 78910
Test Type: WES
Depth: 100x
Quality: Satisfactory
Sequenced: 9/30/2024
Executive Summary - General Genetic Predisposition Report
Whole Exome Sequencing - Research Results
Mendelian Disorder Predictions
We did not predict any Mendelian Disorder associations.
Key Results
- Predisposition to Diseases: The user has been predicted to have a predisposition for 46 diseases. Further steps may include more detailed risk assessments for specific conditions.
- Carrier Status: The presence of certain genetic variants indicates the possibility of being a carrier for genetic conditions. It is recommended to request a Carrier Report for a detailed analysis of any hereditary conditions.
- Treatment Recommendations: Based on the genetic findings, a personalized treatment approach may be beneficial. It is suggested to request a Treatment Report to guide medication and therapy options.
- Next Steps: Schedule a consultation with your healthcare provider to review your results and to discuss the Carrier Report and Treatment Report, which will offer deeper insights into the genetic risks and potential treatment paths.
Please note: This is a sample report with sample data.
*Disclaimers: This report is intended for research use only and is not diagnostic. Please consult with a healthcare provider for diagnoses and next steps.
**Provider recommendation: Please consult a genetic counselor or healthcare provider for next steps. If you do not have a healthcare provider, GeneHealth can assist with matching you to one.
***Treatment explanation: We provide recommendations for compassionate use drugs in cases where traditional treatment options have been exhausted. Treatments are to be discussed with your healthcare provider.
Explore Genetic Insights
Summary
Diseases Found | 46 |
High Risk | 1 |
Medium Risk | 43 |
Low Risk | 2 |
Mutated Genes Found | 21 |
Contents
- Autoimmune Disorders Page 1
- Brain Health (Neurological Disorders) Page 2
- Cancers (Neoplastic Diseases) Page 3
- Dermatological Diseases Page 4
- Endocrine Disorders Page 5
- Gastrointestinal Disorders Page 6
- Genitourinary Disorders Page 7
- Heart Health (Cardiovascular Diseases) Page 8
- Hematological Disorders Page 9
- Metabolic Disorders Page 10
- Musculoskeletal Diseases Page 11
- Obstetric and Gynecological Disorders Page 12
- Ophthalmological Diseases Page 13
- Appendix
Autoimmune Disorders :
The following diseases are associated with Autoimmune Disorders ::
Disease | Predisposition |
---|---|
Immune System Diseases | Medium |
Autoimmune Diseases | Medium |
Connective Tissue Diseases | Low |
Demyelinating Autoimmune Diseases, Cns | Low |
Immune System Diseases
Immune system diseases can broadly be categorized into two types: autoimmune diseases and immunodeficiency diseases. The type of genetic transmission for these diseases can vary: 1. **Autoimmune Diseases**: These are often multifactorial, involving a combination of genetic predisposition and environmental factors. Specific autoimmune diseases can have different patterns of inheritance, including: - **Polygenic Inheritance**: Involves multiple genes (e.g., Type 1 Diabetes, Rheumatoid Arthritis). - **Monogenic Inheritance**: Involves a single gene (less common, e.g., Autoimmune Lymphoproliferative Syndrome). 2. **Immunodeficiency Diseases**: These are often caused by single-gene mutations and can follow various patterns of genetic transmission: - **Autosomal Recessive**: Both copies of the gene must be mutated (e.g., Severe Combined Immunodeficiency [SCID]). - **Autosomal Dominant**: Only one copy of the gene needs to be mutated (e.g., Hyper-IgE Syndrome). - **X-Linked Recessive**: The gene causing the disease is located on the X chromosome (e.g., X-Linked Agammaglobulinemia). Each immune system disease can have a specific genetic transmission pattern that influences its inheritance and manifestation.
Associated Genes
Gene | Mutation Type | Allele | Confidence |
---|---|---|---|
SLC12A7 | Insertion | C/A | Medium |
ANK2 | Deletion | T/A | Medium |
ZFYVE9 | Duplication | T/G | High |
FOXD4 | Substitution | G/G | High |
ACAD9-DT | Inversion | C/A | High |
Population Frequency By Gene
Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.
Gene | Frequency |
---|---|
SLC12A7 | 2% |
ANK2 | 8% |
ZFYVE9 | 17% |
FOXD4 | 6% |
ACAD9-DT | 15% |
Associated Pathways
A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.
Pathway | Type | Effects |
---|---|---|
REACT:R-HSA-6805567 | Hedgehog Signaling Pathway | Critical for embryonic development |
REACT:R-HSA-74160 | Wnt Signaling Pathway | Regulates apoptosis and cell death |
REACT:R-HSA-76002 | Notch Signaling Pathway | Involved in cell growth and survival |
Possible Comobordities
Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.
Gene | Comorbidities | Associated Mechanism |
---|---|---|
SLC12A7 | Stroke | Neurodegeneration |
ANK2 | Osteoporosis | Hormonal imbalance |
ZFYVE9 | Coronary Artery Disease | Immune system dysfunction |
FOXD4 | Asthma | Mitochondrial impairment |
ACAD9-DT | Cancer | Inflammation |
Recommendations for Medium Risk for Immune System Disease
- Consultation: Schedule a follow-up consultation with a primary care provider or genetic counselor.
- Monitoring: Regularly monitor your health for early signs of the condition associated with your predisposition.
- Lifestyle Adjustments: Implement moderate lifestyle changes to mitigate risk.
- Personalized Lifestyle Plan:
- Maintain a balanced diet rich in whole foods, lean protein, and healthy fats.
- Engage in regular physical activity, such as walking, swimming, or light strength training.
- Incorporate stress management techniques like deep breathing exercises or light yoga.
- Limit alcohol consumption and reduce exposure to pollutants.
For additional guidance on managing your predisposition: See treatment options for immune system diseases.
Autoimmune Diseases
Uterine diseases encompass various conditions, including: 1. Uterine fibroids: Benign tumors composed of smooth muscle and fibrous tissue. 2. Endometriosis: Growth of endometrial tissue outside the uterus. 3. Uterine cancer (e.g., endometrial carcinoma): Malignancy in the lining of the uterus. 4. Adenomyosis: Endometrial tissue growing into the uterine muscle. Type of genetic transmission: Most uterine diseases do not follow a simple Mendelian pattern of inheritance. However, there may be genetic predispositions influenced by multiple genetic and environmental factors. For example, uterine fibroids and endometriosis have shown familial clustering, suggesting a hereditary component. Uterine cancer may also have a genetic basis, particularly when associated with hereditary cancer syndromes like Lynch syndrome.
Associated Genes
Gene | Mutation Type | Allele | Confidence |
---|---|---|---|
PUM3 | Frameshift | T/T | Medium |
ANK2 | Deletion | T/C | High |
MRPL36 | Substitution | C/C | Medium |
GSTM4 | Deletion | T/C | High |
TMEM45A | Frameshift | T/C | High |
Population Frequency By Gene
Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.
Gene | Frequency |
---|---|
PUM3 | 3% |
ANK2 | 14% |
MRPL36 | 1% |
GSTM4 | 8% |
TMEM45A | 10% |
Associated Pathways
A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.
Pathway | Type | Effects |
---|---|---|
REACT:R-HSA-6805567 | mTOR Signaling Pathway | Influences inflammatory response |
REACT:R-HSA-76002 | Serotonergic Synapse | Critical for embryonic development |
Possible Comobordities
Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.
Gene | Comorbidities | Associated Mechanism |
---|---|---|
PUM3 | Cancer | Oxidative stress |
ANK2 | Depression | Oxidative stress |
MRPL36 | Cancer | Genetic predisposition |
GSTM4 | Depression | Genetic predisposition |
TMEM45A | Osteoporosis | Metabolic dysregulation |
Recommendations for Medium Risk for Uterine Disease
- Consultation: Schedule a follow-up consultation with a primary care provider or genetic counselor.
- Monitoring: Regularly monitor your health for early signs of the condition associated with your predisposition.
- Lifestyle Adjustments: Implement moderate lifestyle changes to mitigate risk.
- Personalized Lifestyle Plan:
- Maintain a balanced diet rich in whole foods, lean protein, and healthy fats.
- Engage in regular physical activity, such as walking, swimming, or light strength training.
- Incorporate stress management techniques like deep breathing exercises or light yoga.
- Limit alcohol consumption and reduce exposure to pollutants.
For additional guidance on managing your predisposition: See treatment options for Autoimmune Diseases.
Connective Tissue Diseases
Mixed connective tissue disease is an autoimmune disorder. It is not typically considered to have a direct genetic transmission; rather, it is believed to result from a combination of genetic predisposition and environmental factors.
Associated Genes
Gene | Mutation Type | Allele | Confidence |
---|---|---|---|
ZDHHC11 | Deletion | T/A | Medium |
ZNF518B | Inversion | T/T | Medium |
GSTM4 | Inversion | T/A | Medium |
PUM3 | Insertion | G/G | Medium |
GTPBP8 | Deletion | C/C | High |
Population Frequency By Gene
Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.
Gene | Frequency |
---|---|
ZDHHC11 | 6% |
ZNF518B | 15% |
GSTM4 | 17% |
PUM3 | 11% |
GTPBP8 | 7% |
Associated Pathways
A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.
Pathway | Type | Effects |
---|---|---|
REACT:R-HSA-6805567 | NF-kappa B Signaling Pathway | Impacts cellular stress response |
REACT:R-HSA-76002 | MAPK Signaling Pathway | Modulates metabolism and energy use |
Possible Comobordities
Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.
Gene | Comorbidities | Associated Mechanism |
---|---|---|
ZDHHC11 | Parkinson's Disease | Immune system dysfunction |
ZNF518B | Depression | Oxidative stress |
GSTM4 | Chronic Obstructive Pulmonary Disease (COPD) | Oxidative stress |
PUM3 | Coronary Artery Disease | Chronic infection |
GTPBP8 | Cancer | Hormonal imbalance |
Recommendations for Low Risk for Mixed Connective Tissue Disease
- Consultation: Consider discussing results with a healthcare provider for general awareness.
- Health Maintenance: Focus on maintaining overall health and well-being.
- Personalized Lifestyle Plan:
- Eat a diverse diet emphasizing fruits, vegetables, and whole grains.
- Engage in consistent, low-impact physical activity like walking or gardening.
- Prioritize sleep hygiene and ensure adequate rest.
- Minimize exposure to environmental toxins and avoid smoking.
For general wellness recommendations: Explore recommendations for Connective Tissue Diseases.
Demyelinating Autoimmune Diseases, Cns
Demyelinating diseases generally refer to a group of disorders characterized by damage to the myelin sheath of neurons. Some common types include Multiple Sclerosis (MS), Neuromyelitis Optica (NMO), and Acute Disseminated Encephalomyelitis (ADEM). Type of genetic transmission: The genetic component varies by specific demyelinating disease. For example, Multiple Sclerosis is considered to have a complex multifactorial genetic basis, meaning that it is influenced by multiple genetic and environmental factors rather than following a simple Mendelian inheritance pattern.
Associated Genes
Gene | Mutation Type | Allele | Confidence |
---|---|---|---|
PHACTR2 | Deletion | T/A | High |
TMEM45A | Deletion | C/C | High |
FOXD4 | Insertion | A/A | Medium |
MROH2B | Deletion | C/G | Medium |
ANK2 | Deletion | G/G | Medium |
Population Frequency By Gene
Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.
Gene | Frequency |
---|---|
PHACTR2 | 24% |
TMEM45A | 22% |
FOXD4 | 12% |
MROH2B | 9% |
ANK2 | 19% |
Associated Pathways
A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.
Pathway | Type | Effects |
---|---|---|
REACT:R-HSA-6805567 | MAPK Signaling Pathway | Impacts cellular stress response |
Possible Comobordities
Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.
Gene | Comorbidities | Associated Mechanism |
---|---|---|
PHACTR2 | Stroke | Hormonal imbalance |
TMEM45A | Depression | Cellular apoptosis |
FOXD4 | Stroke | Genetic predisposition |
MROH2B | Asthma | Neurodegeneration |
ANK2 | Depression | Immune system dysfunction |
Recommendations for Low Risk for Demyelinating Disease
- Consultation: Consider discussing results with a healthcare provider for general awareness.
- Health Maintenance: Focus on maintaining overall health and well-being.
- Personalized Lifestyle Plan:
- Eat a diverse diet emphasizing fruits, vegetables, and whole grains.
- Engage in consistent, low-impact physical activity like walking or gardening.
- Prioritize sleep hygiene and ensure adequate rest.
- Minimize exposure to environmental toxins and avoid smoking.
For general wellness recommendations: Explore recommendations for demyelinating autoimmune diseases, cns.
Appendix
Mutated Genes Found
Gene | Associated Diseases | Chromosome Position |
---|---|---|
SLC12A7 |
|
Chr11:90543100 |
ANK2 |
|
Chr16:82446024 |
ZFYVE9 |
|
Chr12:27094893 |
FOXD4 |
|
Chr2:99030344 |
ACAD9-DT |
|
Chr12:38259821 |
PUM3 |
|
Chr14:38000947 |
MRPL36 |
|
Chr8:41871276 |
GSTM4 |
|
Chr15:93519304 |
TMEM45A |
|
Chr22:57100312 |
ZDHHC11 |
|
Chr22:54054598 |
ZNF518B |
|
Chr8:73395583 |
GTPBP8 |
|
Chr11:55185227 |
PHACTR2 |
|
Chr17:39266651 |
MROH2B |
|
Chr19:39863981 |
GRM6 |
|
Chr19:50983483 |
NQO2 |
|
Chr9:84005372 |
SDHA |
|
Chr15:43405939 |
ACAD9 |
|
Chr1:56504923 |
LRPPRC |
|
Chr15:37985339 |
ACTN2 |
|
Chr10:14309742 |
FAM110C |
|
Chr13:96811464 |
Diseases Found
Disease | Category | Predisposition |
---|---|---|
immune system diseases | Autoimmune Disorders : | Medium |
Autoimmune Diseases | Autoimmune Disorders : | Medium |
Connective Tissue Diseases | Autoimmune Disorders : | Low |
demyelinating autoimmune diseases, cns | Autoimmune Disorders : | Low |
Alzheimer Disease | Brain Health (Neurological Disorders) | High |
Nervous System Diseases | Brain Health (Neurological Disorders) | Medium |
Neurodegenerative Diseases | Brain Health (Neurological Disorders) | Medium |
Cerebrovascular Disorders | Brain Health (Neurological Disorders) | Medium |
central nervous system diseases | Brain Health (Neurological Disorders) | Medium |
brain diseases, metabolic | Brain Health (Neurological Disorders) | Medium |
neuromuscular diseases | Brain Health (Neurological Disorders) | Medium |
lysosomal storage diseases, nervous system | Brain Health (Neurological Disorders) | Medium |
neurologic manifestations | Brain Health (Neurological Disorders) | Medium |
cranial nerve diseases | Brain Health (Neurological Disorders) | Medium |
Spinal Cord Ischemia | Brain Health (Neurological Disorders) | Medium |
genital neoplasms, male | Cancers (Neoplastic Diseases) | Medium |
Prostatic Neoplasms | Cancers (Neoplastic Diseases) | Medium |
Breast Neoplasms | Cancers (Neoplastic Diseases) | Medium |
Gastrointestinal Neoplasms | Cancers (Neoplastic Diseases) | Medium |
Digestive System Neoplasms | Cancers (Neoplastic Diseases) | Medium |
skin and connective tissue diseases | Dermatological Diseases : | Medium |
Endocrine System Diseases | Endocrine Disorders : | Medium |
digestive system diseases | Gastrointestinal Disorders : | Medium |
Gastrointestinal Diseases | Gastrointestinal Disorders : | Medium |
Intestinal Diseases | Gastrointestinal Disorders : | Medium |
Male Urogenital Diseases | Genitourinary Disorders : | Medium |
Cardiovascular Abnormalities | Heart Health (Cardiovascular Diseases) | Medium |
Cardiomyopathy, Hypertrophic | Heart Health (Cardiovascular Diseases) | Medium |
Vascular Diseases | Heart Health (Cardiovascular Diseases) | Medium |
Hypertension | Heart Health (Cardiovascular Diseases) | Medium |
Coronary Artery Disease | Heart Health (Cardiovascular Diseases) | Medium |
hemic and lymphatic diseases | Hematological Disorders : | Medium |
Hematologic Diseases | Hematological Disorders : | Medium |
Blood Coagulation Disorders | Hematological Disorders : | Medium |
Hemorrhagic Disorders | Hematological Disorders : | Medium |
Thrombophilia | Hematological Disorders : | Medium |
carbohydrate metabolism, inborn errors | Metabolic Disorders : | Medium |
lipid metabolism disorders | Metabolic Disorders : | Medium |
lipidoses | Metabolic Disorders : | Medium |
Obesity | Metabolic Disorders : | Medium |
Diabetes Mellitus, Type 1 | Metabolic Disorders : | Medium |
Lipid Metabolism, Inborn Errors | Metabolic Disorders : | Medium |
musculoskeletal diseases | Musculoskeletal Diseases : | Medium |
Muscular Diseases | Musculoskeletal Diseases : | Medium |
female urogenital diseases and pregnancy complications | Obstetric and Gynecological Disorders : | Medium |
female urogenital diseases and pregnancy complications | Ophthalmological Diseases : | Medium |